The DOI matches its Crossref record; 369 of the 369 references it cites were found in a registry or an index.
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Open accessAbstract
The relative insufficiency of insulin secretion and/or insulin action causes diabetes. However, obesity and type 2 diabetes mellitus can be associated with an absolute increase in circulating insulin, a state known as hyperinsulinemia. Studies are beginning to elucidate the cause-effect relationships between hyperinsulinemia and numerous consequences of metabolic dysfunctions. Here, we review recent evidence demonstrating that hyperinsulinemia may play a role in inflammation, aging and development of cancers. In this review, we will focus on the consequences and mechanisms of excess insulin production and action, placing recent findings that have challenged dogma in the context of the existing body of literature. Where relevant, we elaborate on the role of specific signal transduction components in the actions of insulin and consequences of chronic hyperinsulinemia. By discussing the involvement of hyperinsulinemia in various metabolic and other chronic diseases, we may identify more effective therapeutics or lifestyle interventions for preventing or treating obesity, diabetes and cancer. We also seek to identify pertinent questions that are ripe for future investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 307
RetractedPearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 265
RetractedOverexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
Wang, C., Zhang, G., Zhao, L., Qi, W., Li, X., Wang, J., & Wei, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069001 · Cited by 55
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
The Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916
Liao, J., Wei, Q., Zou, Y., Fan, J., Song, D., Cui, J., Zhang, W., Zhu, Y., Ma, C., Hu, X., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471945 · Cited by 2,742
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611 · cited 1×
“Several studies suggest that obesity-associated, chronic, low-grade inflammation can cause insulin resistance in metabolic tissues like liver, muscle, and adipose tissues [134-136].”
BackgroundRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
BRST Cohomology of the Chapline-Manton Model
Barnich, G., Leclercq, S., & Spindel, P. (1997) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · doi:10.1023/b · Cited by 2,179
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140 · cited 1×
“T-cell activation requires glucose and glutamine metabolism [153,156-158].”
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“Reducing fasting insulin with low carbohydrate diets, caloric restriction, or time-restricted feeding improves insulin sensitivity in mice and humans and may lead to T2DM remission [103-106].”
BackgroundLi, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,719
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636 · cited 1×
“Clinical trials have shown that prolonged elevation of exogenous long-acting insulin analogues causes weight gain [113].”
Tatar, M., Kopelman, A., Epstein, D., Tu, M.-P., Yin, C.-M., & Garofalo, R. S. (2001) · Science · doi:10.1126/science.1057987 · Cited by 1,628
Sutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
Extension of Life-Span by Loss of CHICO, a Drosophila Insulin Receptor Substrate Protein
Clancy, D. J., Gems, D., Harshman, L. G., Oldham, S., Stocker, H., Hafen, E., Leevers, S. J., & Partridge, L. (2001) · Science · doi:10.1126/science.1057991 · Cited by 1,436
Normalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
Singh, N., Baby, D., Rajguru, J., Patil, P., Thakkannavar, S., & Pujari, V. (2019) · Annals of African Medicine · doi:10.4103/aam.aam_56_18 · Cited by 1,333
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue
Blüher, M., Kahn, B. B., & Kahn, C. R. (2003) · Science · doi:10.1126/science.1078223 · Cited by 1,155
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124 · cited 2×
“Some epidemiological studies report increased cancer risk in patients receiving exogenous long-acting insulins as diabetes therapy [182-187], but these findings were controversial and subsequent studies have failed to find a consistent association [188-191].”
BackgroundResultType-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes
Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009 · cited 1×
“Retrospective studies show that metformin, which reduces hyperinsulinemia, may lower pancreatic cancer risk in animals [292] and in patients by up to 60% [182,293-297], although the magnitude of this effect is controversial [298,299] and it is unclear whether metformin acts via lowering insulin or modulating AMP-activ…”
BackgroundThe role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Obesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Blüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Insulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
Polonsky, K. S., Given, B. D., & Van Cauter, E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113339 · Cited by 763
(1922) · PubMed · Cited by 753
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 3×
“When insulin binds to INSR, it causes receptor autophosphorylation and activation of the PI3K/AKT/mTOR signaling cascade [42].”
BackgroundMacrophages, Immunity, and Metabolic Disease
McNelis, J. C., & Olefsky, J. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.010 · Cited by 720
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G., Baskin, D. G., & Rossetti, L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-861 · Cited by 719
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706 · cited 1×
“For instance, a recent study showed that the combination of PI3K inhibitors with kenogenetic diet or sodium-glucose transport protein 2 (SGLT2) inhibitors can effectively reduce tumor growth and increase the survival rate [366].”
BackgroundMechanisms of nutritional and hormonal regulation of lipogenesis
Kersten, S. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve071 · Cited by 700
Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · cited 3×
“We again used female mice with lower fasting insulin without affecting the glucose homeostasis (Ins1+/−; Ins2−/− compared to Ins1+/+; Ins2−/−) [20,30] that also expressed commonly used pancreatic cancer susceptibility alleles that reflect human disease genetics (Ptf1aCreER; LSL-KrasG12D) [258].”
Self-citationPLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Regulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017) · Population Health Management · doi:10.1089/pop.2015.0181 · Cited by 655
Kaaks, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1592 · Cited by 653
The Origins and Drivers of Insulin Resistance
Johnson, A. M. F., & Olefsky, J. M. (2013) · Cell · doi:10.1016/j.cell.2013.01.041 · Cited by 643
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
Onstad, M. A., Schmandt, R. E., & Lu, K. H. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4638 · Cited by 643
The TSC-mTOR pathway regulates macrophage polarization
Byles, V., Covarrubias, A. J., Ben-Sahra, I., Lamming, D. W., Sabatini, D. M., Manning, B. D., & Horng, T. (2013) · Nature Communications · doi:10.1038/ncomms3834 · Cited by 633
Neuhouser, M. L., Aragaki, A. K., Prentice, R. L., Manson, J. E., Chlebowski, R., Carty, C. L., Ochs-Balcom, H. M., Thomson, C. A., Caan, B. J., Tinker, L. F., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1546 · Cited by 630
Obesity and impaired metabolic health in patients with COVID-19
Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0364-6 · Cited by 626
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200070 · Cited by 615
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms
Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M. T., Ventura, V., Foti, D., Chiefari, E., & Brunetti, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/789174 · Cited by 606
EPIC-InterAct Consortium, Lotta, L. A., Cambridge FPLD1 Consortium, Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3714 · Cited by 585
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., Ramadani, F., Okkenhaug, K., Schuster, E., Blanc, E., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9261com · Cited by 532
Obesity: Overview of an Epidemic
Mitchell, N. S., Catenacci, V. A., Wyatt, H. R., & Hill, J. O. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.005 · Cited by 526
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202766200 · Cited by 500
Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production
Mehran, A. E., Templeman, N. M., Brigidi, G. S., Lim, G. E., Chu, K.-Y., Hu, X., Botezelli, J. D., Asadi, A., Hoffman, B. G., Kieffer, T. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.019 · Cited by 498
Self-citationInsulin resistance causes inflammation in adipose tissue
Shimobayashi, M., Albert, V., Woelnerhanssen, B., Frei, I. C., Weissenberger, D., Meyer-Gerspach, A. C., Clement, N., Moes, S., Colombi, M., Meier, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96139 · Cited by 480
The cell biology of systemic insulin function
Tokarz, V. L., MacDonald, P. E., & Klip, A. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201802095 · Cited by 471 · cited 2×
“Hyperinsulinemia can manifest as an elevation in basal/fasting circulating insulin and/or as a potentiation of post-prandial insulin secretion [71,72], and can result from insulin hypersecretion or reduced systemic insulin clearance, or both [73-76].”
BackgroundTaylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
The Carbohydrate-Insulin Model of Obesity: Beyond “Calories In, Calories Out”
Ludwig, D. S., & Ebbeling, C. B. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2933 · Cited by 440
Control of macrophage metabolism and activation by mTOR and Akt signaling
Covarrubias, A. J., Aksoylar, H. I., & Horng, T. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.08.001 · Cited by 424
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Hallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., Hazbun, T. L., Volk, B. M., McCarter, J. P., Phinney, S. D., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0373-9 · Cited by 406 · cited 1×
“Reducing fasting insulin with low carbohydrate diets, caloric restriction, or time-restricted feeding improves insulin sensitivity in mice and humans and may lead to T2DM remission [103-106].”
BackgroundInsulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
Stolzenberg-Solomon, R. Z. (2005) · JAMA · doi:10.1001/jama.294.22.2872 · Cited by 400
(2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70301-2 · Cited by 399
Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., Hu, F. B., & Giovannucci, E. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv088 · Cited by 395
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Nutritional Regulation of IGF-I and IGF Binding Proteins
Clemmons, D. R., & Underwood, L. E. (1991) · Annual Review of Nutrition · doi:10.1146/annurev.nu.11.070191.002141 · Cited by 387
Metformin: Taking away the candy for cancer?
Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 380
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 375
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369
Kulkarni, R. N., Holzenberger, M., Shih, D. Q., Ozcan, U., Stoffel, M., Magnuson, M. A., & Kahn, C. R. (2002) · Nature Genetics · doi:10.1038/ng872 · Cited by 363
Insulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity
Pawlikowska, L., Hu, D., Huntsman, S., Sung, A., Chu, C., Chen, J., Joyner, A. H., Schork, N. J., Hsueh, W., Reiner, A. P., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00493.x · Cited by 352
Saraei, P., Asadi, I., Kakar, M. A., & Moradi-Kor, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s200059 · Cited by 350
Pancreatic Extracts in The Treatment of Diabetes Mellitus
Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R., & Fletcher, A. A. (1956) · Diabetes · doi:10.2337/diab.5.1.69 · Cited by 347
Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study
Michels, K. B., Solomon, C. G., Hu, F. B., Rosner, B. A., Hankinson, S. E., Colditz, G. A., & Manson, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1752 · Cited by 341
Diabetes and cause-specific mortality in a prospective cohort of one million U.S. Adults
Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E. J., & Gapstur, S. M. (2012) · Diabetes Care · doi:10.2337/dc12-0002 · Cited by 339
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338 · cited 1×
“The increase of INSR-A/INSRB ratio has been found in breast [46,232-236], prostate [237239], endometrial [240,241], colon [242], and lung cancers [242-244].”
BackgroundRisk Factors for Pancreatic Cancer: Case-Control Study
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., Evans, D. B., Khan, R., Chou, T.-H., Lenzi, R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01510.x · Cited by 331
Denduluri, S. K., Idowu, O., Wang, Z., Liao, Z., Yan, Z., Mohammed, M. K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.10.004 · Cited by 331
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 329
Prevention of pancreatic cancer induction in hamsters by metformin
Schneider, M. B., Matsuzaki, H., Haorah, J., Ulrich, A., Standop, J., Ding, X., Adrian, T. E., & Pour, P. M. (2001) · Gastroenterology · doi:10.1053/gast.2001.23258 · Cited by 327
A case-control study of diabetes mellitus and cancer risk
La Vecchia, C., Negri, E., Franceschi, S., D'Avanzo, B., & Boyle, P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.427 · Cited by 320
Metformin in cancer prevention and therapy.
Kasznicki, J., Śliwińska, A., & Drzewoski, J. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.01 · Cited by 316
Kisfalvi, K., Eibl, G., Sinnett-Smith, J., & Rozengurt, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0418 · Cited by 315
Patton, D. T., Garden, O. A., Pearce, W. P., Clough, L. E., Monk, C. R., Leung, E., Rowan, W. C., Sancho, S., Walker, L. S. K., Vanhaesebroeck, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6598 · Cited by 303
The insulin paradox: aging, proteotoxicity and neurodegeneration
Cohen, E., & Dillin, A. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2474 · Cited by 303
Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial
Lustig, R. H., Hinds, P. S., Ringwald-Smith, K., Christensen, R. K., Kaste, S. C., Schreiber, R. E., Rai, S. N., Lensing, S. Y., Wu, S., & Xiong, X. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030003 · Cited by 299
Macrophage infiltration into adipose tissue: initiation, propagation and remodeling
Surmi, B., & Hasty, A. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.545 · Cited by 299
Corkey, B. E. (2012) · Diabetes · doi:10.2337/db11-1483 · Cited by 285
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Insulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
Luyendyk, J. P., Schabbauer, G. A., Tencati, M., Holscher, T., Pawlinski, R., & Mackman, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4218 · Cited by 273
Odeleye, O. E., de Courten, M., Pettitt, D. J., & Ravussin, E. (1997) · Diabetes · doi:10.2337/diab.46.8.1341 · Cited by 273
Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
Tsai, S., Clemente-Casares, X., Zhou, A. C., Lei, H., Ahn, J. J., Chan, Y. T., Choi, O., Luck, H., Woo, M., Dunn, S. E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.003 · Cited by 272
Phenotypic alterations in insulin-deficient mutant mice
Duvillié, B., Cordonnier, N., Deltour, L., Dandoy-Dron, F., Itier, J.-M., Monthioux, E., Jami, J., Joshi, R. L., & Bucchini, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5137 · Cited by 272
Central insulin action regulates peripheral glucose and fat metabolism in mice
Koch, L., Wunderlich, F. T., Seibler, J., Könner, A. C., Hampel, B., Irlenbusch, S., Brabant, G., Kahn, C. R., Schwenk, F., & Brüning, J. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31073 · Cited by 271
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Manson, J. E., Li, J., Harris, T. G., Rohan, T. E., Xue, X., Ho, G. Y. F., et al. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2686 · Cited by 267
RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon.
Soares, M. B., Schon, E., Henderson, A., Karathanasis, S. K., Cate, R., Zeitlin, S., Chirgwin, J., & Efstratiadis, A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.2090 · Cited by 264
Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., Davey Smith, G., & Brennan, P. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx012 · Cited by 263
Brain Insulin Controls Adipose Tissue Lipolysis and Lipogenesis
Scherer, T., O'Hare, J., Diggs-Andrews, K., Schweiger, M., Cheng, B., Lindtner, C., Zielinski, E., Vempati, P., Su, K., Dighe, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.008 · Cited by 262
Insulin Receptor Knockout Mice
Kitamura, T., Kahn, C. R., & Accili, D. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142540 · Cited by 260
The multiple facets of mTOR in immunity
Weichhart, T., & Säemann, M. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.02.002 · Cited by 259
Ley, K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701135 · Cited by 259
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetes
Ueki, K., Okada, T., Hu, J., Liew, C. W., Assmann, A., Dahlgren, G. M., Peters, J. L., Shackman, J. G., Zhang, M., Artner, I., et al. (2006) · Nature Genetics · doi:10.1038/ng1787 · Cited by 257
Glucose transporter expression on the plasma membrane of resting and activated white blood cells
Maratou, E., Dimitriadis, G., Kollias, A., Boutati, E., Lambadiari, V., Mitrou, P., & Raptis, S. A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01786.x · Cited by 251
Colorectal cancer mortality and factors related to the insulin resistance syndrome.
Colangelo, L. A., Gapstur, S. M., Gann, P. H., Dyer, A. R., & Liu, K. (2002) · PubMed · Cited by 250
Quantitative Estimation of the Pancreatic Islet Tissue in Diabetic Subjects
Maclean, N., & Ogilvie, R. F. (1955) · Diabetes · doi:10.2337/diab.4.5.367 · Cited by 248
van der Burg, B., Rutteman, G. R., Blankenstein, M. A., de Laat, S. W., & van Zoelen, E. J. J. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340112 · Cited by 247
Hepatic Insulin Clearance: Mechanism and Physiology
Najjar, S. M., & Perdomo, G. (2019) · Physiology · doi:10.1152/physiol.00048.2018 · Cited by 246
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Do, R., Bailey, S. D., Desbiens, K., Belisle, A., Montpetit, A., Bouchard, C., Pérusse, L., Vohl, M.-C., & Engert, J. C. (2008) · Diabetes · doi:10.2337/db07-1267 · Cited by 237
Ulanet, D. B., Ludwig, D. L., Kahn, C. R., & Hanahan, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914076107 · Cited by 235
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity
Pal, A., Barber, T. M., Van de Bunt, M., Rudge, S. A., Zhang, Q., Lachlan, K. L., Cooper, N. S., Linden, H., Levy, J. C., Wakelam, M. J. O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113966 · Cited by 234
Permuth-Wey, J., & Egan, K. M. (2009) · Familial Cancer · doi:10.1007/s10689-008-9214-8 · Cited by 232
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Insulin/IGF-like signalling, the central nervous system and aging
Broughton, S., & Partridge, L. (2009) · Biochemical Journal · doi:10.1042/bj20082102 · Cited by 228
Leptin and Insulin Action in the Central Nervous System
Porte, D., Baskin, D. G., & Schwartz, M. W. (2002) · Nutrition Reviews · doi:10.1301/002966402320634797 · Cited by 228
Bernal-Mizrachi, E., Fatrai, S., Johnson, J. D., Ohsugi, M., Otani, K., Han, Z., Polonsky, K. S., & Permutt, M. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20016 · Cited by 225
Self-citationInsulin receptor expression by human prostate cancers
Cox, M. E., Gleave, M. E., Zakikhani, M., Bell, R. H., Piura, E., Vickers, E., Cunningham, M., Larsson, O., Fazli, L., & Pollak, M. (2009) · The Prostate · doi:10.1002/pros.20852 · Cited by 223
Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans
Conover, C. A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1355 · Cited by 223
The Insulin Receptor and Its Cellular Targets1
Kido, Y., Nakae, J., & Accili, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7306 · Cited by 223
Adiposity signals and food reward: expanding the CNS roles of insulin and leptin
Figlewicz, D. P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00602.2002 · Cited by 221
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Chlebowski, R. T., McTiernan, A., Wactawski-Wende, J., Manson, J. E., Aragaki, A. K., Rohan, T., Ipp, E., Kaklamani, V. G., Vitolins, M., Wallace, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7505 · Cited by 214
Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
Hammarsten, J., & Högstedt, B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.003 · Cited by 214
Reduction of food intake and body weight by chronic intraventricular insulin infusion
Brief, D. J., & Davis, J. D. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90174-6 · Cited by 212
Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
Martin-Castillo, B., Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 212
Ma, S., Bonaventure, P., Ferraro, T., Shen, P.-J., Burazin, T. C. D., Bathgate, R. A. D., Liu, C., Tregear, G. W., Sutton, S. W., & Gundlach, A. L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.072 · Cited by 209
Insulin receptor expression and function in human breast cancer cell lines.
Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., & Belfiore, A. (1992) · PubMed · Cited by 206
Sharma, A., Smyrk, T. C., Levy, M. J., Topazian, M. A., & Chari, S. T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.025 · Cited by 204
Diabetes, prediabetes and cancer mortality
for the DECODE Study Group, Zhou, X. H., Qiao, Q., Zethelius, B., Pyörälä, K., Söderberg, S., Pajak, A., Stehouwer, C. D. A., Heine, R. J., Jousilahti, P., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1796-7 · Cited by 197
Stockhorst, U., de Fries, D., Steingrueber, H.-J., & Scherbaum, W. A. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.07.022 · Cited by 192
Bornstein, S. R., Abu-Asab, M., Glasow, A., Päth, G., Hauner, H., Tsokos, M., Chrousos, G. P., & Scherbaum, W. A. (2000) · Diabetes · doi:10.2337/diabetes.49.4.532 · Cited by 189
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome
Johnson, J. D., Bernal-Mizrachi, E., Alejandro, E. U., Han, Z., Kalynyak, T. B., Li, H., Beith, J. L., Gross, J., Warnock, G. L., Townsend, R. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604208103 · Cited by 188
Self-citationReduced Insulin Production Relieves Endoplasmic Reticulum Stress and Induces β Cell Proliferation
Szabat, M., Page, M. M., Panzhinskiy, E., Skovsø, S., Mojibian, M., Fernandez-Tajes, J., Bruin, J. E., Bround, M. J., Lee, J. T. C., Xu, E. E., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.016 · Cited by 187
Self-citationKATZENELLENBOGEN, B. S., & JANE NORMAN, M. (1990) · Endocrinology · doi:10.1210/endo-126-2-891 · Cited by 185
Parekh, N., Chandran, U., & Bandera, E. V. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150713 · Cited by 184
Thymus‐specific deletion of insulin induces autoimmune diabetes
Fan, Y., Rudert, W. A., Grupillo, M., He, J., Sisino, G., & Trucco, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.212 · Cited by 183
Koorstra, J.-B. M., Hustinx, S. R., Offerhaus, G. J. A., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000123838 · Cited by 183
Boyd, D. B. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403259152 · Cited by 182
Lawlor, D. A., Smith, G. D., & Ebrahim, S. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000024225.14618.a8 · Cited by 182
Venkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H., & Pollak, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm231 · Cited by 182
Insulin Inhibits IL-10–Mediated Regulatory T Cell Function: Implications for Obesity
Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302181 · Cited by 179
Risk factors for pancreatic cancer
Lowenfels, A. B., & Maisonneuve, P. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20461 · Cited by 177
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
Becker, S., Dossus, L., & Kaaks, R. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902878054 · Cited by 177
Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood
Lee, S.-H., Zabolotny, J. M., Huang, H., Lee, H., & Kim, Y.-B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.011 · Cited by 176
Viardot, A., Grey, S. T., Mackay, F., & Chisholm, D. (2007) · Endocrinology · doi:10.1210/en.2006-0686 · Cited by 174
Krogh‐Madsen, R., Plomgaard, P., Keller, P., Keller, C., & Pedersen, B. K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2003 · Cited by 174
Insulin Promotes Pancreatic Cancer: Evidence for Endocrine Influence on Exocrine Pancreatic Tumors
Fisher, W. E., Boros, L. G., & Schirmer, W. J. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0266 · Cited by 172
Webster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 171
The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland.
Henderson, J. R., Daniel, P. M., & Fraser, P. A. (1981) · Gut · doi:10.1136/gut.22.2.158 · Cited by 170
A causal role for hyperinsulinemia in obesity
Templeman, N. M., Skovsø, S., Page, M. M., Lim, G. E., & Johnson, J. D. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0449 · Cited by 168
Converging Pathways in Lifespan Regulation
Narasimhan, S. D., Yen, K., & Tissenbaum, H. A. (2009) · Current Biology · doi:10.1016/j.cub.2009.06.013 · Cited by 168
Comparative Analysis of Insulin Gene Promoters
Hay, C. W., & Docherty, K. (2006) · Diabetes · doi:10.2337/db06-0788 · Cited by 168
Characterization of the two nonallelic genes encoding mouse preproinsulin
Wentworth, B. M., Schaefer, I. M., Villa-Komaroff, L., & Chirgwin, J. M. (1986) · Journal of Molecular Evolution · doi:10.1007/bf02100639 · Cited by 166
Sahin, E., Haubenwallner, S., Kuttke, M., Kollmann, I., Halfmann, A., Dohnal, A. M., Chen, L., Cheng, P. P., Hoesel, B., Einwallner, E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302167 · Cited by 166
ACTION OF INSULIN ON DEPOSITION OF GLYCOGEN AND STORAGE OF FAT IN ADIPOSE TISSUE
RENOLD, A. E., MARBLE, A., & FAWCETT, D. W. (1950) · Endocrinology · doi:10.1210/endo-46-1-55 · Cited by 165
Pancreatic Cancer: A Review of the Evidence on Causation
Hart, A. R., Kennedy, H. J., & Harvey, I. M. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.12.041 · Cited by 165
Yuan, S., Kar, S., Carter, P., Vithayathil, M. K., Mason, A. M., Burgess, S., & Larsson, S. C. (2020) · Diabetes · doi:10.2337/db20-0084 · Cited by 164
Vergadi, E., Vaporidi, K., Theodorakis, E. E., Doxaki, C., Lagoudaki, E., Ieronymaki, E., Alexaki, V. I., Helms, M., Kondili, E., Soennichsen, B., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300959 · Cited by 163
Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Orliaguet, L., Dalmas, É., Drareni, K., Venteclef, N., & Alzaïd, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00062 · Cited by 162
Hyperinsulinemia: A cause of obesity?
Erion, K. A., & Corkey, B. E. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0261-z · Cited by 161
Stevens, R. J., Ali, R., Bankhead, C. R., Bethel, M. A., Cairns, B. J., Camisasca, R. P., Crowe, F. L., Farmer, A. J., Harrison, S., Hirst, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2653-7 · Cited by 161
Reduced Circulating Insulin Enhances Insulin Sensitivity in Old Mice and Extends Lifespan
Templeman, N. M., Flibotte, S., Chik, J. H. L., Sinha, S., Lim, G. E., Foster, L. J., Nislow, C., & Johnson, J. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.048 · Cited by 161
Self-citationLifestyle and endometrial cancer risk: a cohort study from the Swedish twin registry
Terry, P., Baron, J. A., Weiderpass, E., Yuen, J., Lichtenstein, P., & Nyr�n, O. (1999) · International Journal of Cancer · Cited by 160
Diabetes and endometrial cancer in the Iowa women's health study.
Anderson, K. E., Anderson, E. L., Mink, P. J., Hong, C. P., Kushi, L. H., Sellers, T. A., Lazovich, D., & Folsom, A. R. (2001) · PubMed · Cited by 160
Does Reduced IGF-1R Signaling in Igf1r+/− Mice Alter Aging?
Bokov, A. F., Garg, N., Ikeno, Y., Thakur, S., Musi, N., DeFronzo, R. A., Zhang, N., Erickson, R. C., Gelfond, J., Hubbard, G. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026891 · Cited by 159
The role of insulin and IGF-1 signaling in longevity
Katic, M., & Kahn, C. R. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4297-y · Cited by 159
Islet Microvasculature in Islet Hyperplasia and Failure in a Model of Type 2 Diabetes
Li, X., Zhang, L., Meshinchi, S., Dias-Leme, C. L., Raffin, D., Johnson, J. D., Treutelaar, M. K., & Burant, C. (2006) · Diabetes · doi:10.2337/db06-0733 · Cited by 158
Self-citationDawson, D. W., Hertzer, K. M., Moro, A., Donald, G. W., Chang, H.-H., Go, V. L. W., Pandol, S. J., Lugea, A., Gukovskaya, A. S., Li, G., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0065 · Cited by 158
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
Johnson, J. A., & Bowker, S. L. (2010) · Diabetologia · doi:10.1007/s00125-010-1933-3 · Cited by 157
Self-citation
Cited by
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 499
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2021-05-31
- Volume
- 45
- Issue
- 3
- Pages
- 285-311
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- OpenAlex
- W3144197674
- Cited by
- 305
- References
- 369
- FWCI
- 23.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.